Hypoglycemia In Type 2 Diabetes: Current Controversies and Changing Practices

Hypoglycemia is well-recognized to limit the degree of glycemic control possible for many individuals for diabetes. Although the likelihood of hypoglycemia increases as A1c levels decrease in type 1 diabetes, insulin-treated type 2 diabetic persons with higher A1c appear paradoxically to have more...

Full description

Bibliographic Details
Main Authors: Zachary eBloomgarden, Daniel eEinhorn
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-05-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fendo.2012.00066/full
id doaj-e97d78ee3c9e4177877575322c5a261d
record_format Article
spelling doaj-e97d78ee3c9e4177877575322c5a261d2020-11-25T02:29:36ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922012-05-01310.3389/fendo.2012.0006621960Hypoglycemia In Type 2 Diabetes: Current Controversies and Changing PracticesZachary eBloomgarden0Daniel eEinhorn1Mount Sinai School of MedicineScripps Whittier Institute for DiabetesHypoglycemia is well-recognized to limit the degree of glycemic control possible for many individuals for diabetes. Although the likelihood of hypoglycemia increases as A1c levels decrease in type 1 diabetes, insulin-treated type 2 diabetic persons with higher A1c appear paradoxically to have more hypoglycemia; this may in part explain the adverse outcome reported in the ACCORD study. Approaches to glucose-lowering causing lesser degrees of hypoglycemia, technologies to better ascertain hypoglycemic events, and better understanding of patient characteristics associated with greater likelihood of hypoglycemia will all be required to reduce this limiting factor in optimizing glycemic treatment.http://journal.frontiersin.org/Journal/10.3389/fendo.2012.00066/fullHypoglycemiahemoglobin A1ctype 2 diabetesglycemic controlinsulin therapy
collection DOAJ
language English
format Article
sources DOAJ
author Zachary eBloomgarden
Daniel eEinhorn
spellingShingle Zachary eBloomgarden
Daniel eEinhorn
Hypoglycemia In Type 2 Diabetes: Current Controversies and Changing Practices
Frontiers in Endocrinology
Hypoglycemia
hemoglobin A1c
type 2 diabetes
glycemic control
insulin therapy
author_facet Zachary eBloomgarden
Daniel eEinhorn
author_sort Zachary eBloomgarden
title Hypoglycemia In Type 2 Diabetes: Current Controversies and Changing Practices
title_short Hypoglycemia In Type 2 Diabetes: Current Controversies and Changing Practices
title_full Hypoglycemia In Type 2 Diabetes: Current Controversies and Changing Practices
title_fullStr Hypoglycemia In Type 2 Diabetes: Current Controversies and Changing Practices
title_full_unstemmed Hypoglycemia In Type 2 Diabetes: Current Controversies and Changing Practices
title_sort hypoglycemia in type 2 diabetes: current controversies and changing practices
publisher Frontiers Media S.A.
series Frontiers in Endocrinology
issn 1664-2392
publishDate 2012-05-01
description Hypoglycemia is well-recognized to limit the degree of glycemic control possible for many individuals for diabetes. Although the likelihood of hypoglycemia increases as A1c levels decrease in type 1 diabetes, insulin-treated type 2 diabetic persons with higher A1c appear paradoxically to have more hypoglycemia; this may in part explain the adverse outcome reported in the ACCORD study. Approaches to glucose-lowering causing lesser degrees of hypoglycemia, technologies to better ascertain hypoglycemic events, and better understanding of patient characteristics associated with greater likelihood of hypoglycemia will all be required to reduce this limiting factor in optimizing glycemic treatment.
topic Hypoglycemia
hemoglobin A1c
type 2 diabetes
glycemic control
insulin therapy
url http://journal.frontiersin.org/Journal/10.3389/fendo.2012.00066/full
work_keys_str_mv AT zacharyebloomgarden hypoglycemiaintype2diabetescurrentcontroversiesandchangingpractices
AT danieleeinhorn hypoglycemiaintype2diabetescurrentcontroversiesandchangingpractices
_version_ 1724832082008473600